Meredith Manning - 22 Apr 2024 Form 3 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Commercial Officer
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
22 Apr 2024
Net transactions value
$0
Form type
3
Filing time
30 Apr 2024, 17:54:49 UTC
Next filing
19 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLNO Employee stock option (right to buy) 22 Apr 2024 Common Stock 128,000 $46.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option shall vest on January 23, 2025 and one-forty-eighth of the shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.

Remarks:

Exhibit 24 - Power of Attorney